Literature DB >> 24925454

Partial rescue of memory deficits induced by calorie restriction in a mouse model of tau deposition.

Milene L Brownlow1, Aurelie Joly-Amado1, Sana Azam2, Mike Elza2, Maj-Linda Selenica3, Colleen Pappas4, Brent Small4, Robert Engelman5, Marcia N Gordon1, Dave Morgan6.   

Abstract

Calorie restriction (CR) was shown previously to improve cognition and decrease pathology in transgenic mouse models with Alzheimer-like amyloid deposition. In the present study, we investigated the effects of CR on the Tg4510 model of tau deposition. Mice in the calorie restriction group had food intake gradually decreased until they reached an average of 35% body weight reduction. Body weight and food intake were monitored throughout the study. After being on their respective diets for 3 months, all animals were submitted to behavioral testing. Tg4510 mice fed ad libitum showed lower body weight than nontransgenic littermates despite their increased food intake. Additionally, Tg4510 showed increased locomotor activity in the open field regardless of diet. Calorie restricted Tg4510 mice performed significantly better than ad libitum fed mice in the novel object recognition test, suggesting improved short-term memory. CR Tg4510 mice also performed significantly better in contextual fear conditioning than mice fed ad libitum. However, in a modified version of the novelty test that allows for interaction with other mice instead of inanimate objects, CR was not able to rescue the deficit found in Tg4510 mice in this ethologically more salient version of the task. No treatment differences in motor performance or spatial memory were observed in the rotarod or radial arm water maze tests, respectively. Histopathological and biochemical assessments showed no diet-induced changes in total or phospho-tau levels. Moreover, increased activation of both astrocytes and microglia in Tg4510 mice was not rescued by calorie restriction. Taken together, our data suggests that, despite an apparent rescue of associative memory, CR had no consistent effects on pathological outcomes of a mouse model of tau deposition.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Body weight; Dietary restriction; Food intake; Novel object recognition; Tauopathy

Mesh:

Substances:

Year:  2014        PMID: 24925454     DOI: 10.1016/j.bbr.2014.06.001

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  26 in total

Review 1.  Nutritional strategies to optimise cognitive function in the aging brain.

Authors:  Devin Wahl; Victoria C Cogger; Samantha M Solon-Biet; Rosilene V R Waern; Rahul Gokarn; Tamara Pulpitel; Rafael de Cabo; Mark P Mattson; David Raubenheimer; Stephen J Simpson; David G Le Couteur
Journal:  Ageing Res Rev       Date:  2016-06-26       Impact factor: 10.895

2.  Dietary Energy Restriction Ameliorates Cognitive Impairment in a Mouse Model of Traumatic Brain Injury.

Authors:  V Rubovitch; A Pharayra; M Har-Even; O Dvir; M P Mattson; C G Pick
Journal:  J Mol Neurosci       Date:  2019-02-08       Impact factor: 3.444

Review 3.  Caloric restriction: beneficial effects on brain aging and Alzheimer's disease.

Authors:  Caroline Van Cauwenberghe; Charysse Vandendriessche; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mamm Genome       Date:  2016-05-30       Impact factor: 2.957

4.  Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.

Authors:  Bae Kun Shin; Suna Kang; Da Sol Kim; Sunmin Park
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

5.  Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.

Authors:  Deng-Lei Ma; Yi Luo; Rui Huang; Zi-Run Zhao; Li Zhang; Ya-Li Li; Qi Wang; Lin Li; Lan Zhang
Journal:  Curr Med Sci       Date:  2021-01-11

Review 6.  Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Authors:  Rebekah M Ahmed; Yazi D Ke; Steve Vucic; Lars M Ittner; William Seeley; John R Hodges; Olivier Piguet; Glenda Halliday; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2018-03-23       Impact factor: 42.937

Review 7.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

8.  Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke.

Authors:  Jennifer L Au; Nina Weishaupt; Hayley J Nell; Shawn N Whitehead; David F Cechetto
Journal:  J Vis Exp       Date:  2016-03-22       Impact factor: 1.355

Review 9.  Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies.

Authors:  Sulana K Schroeder; Aurelie Joly-Amado; Marcia N Gordon; Dave Morgan
Journal:  J Neuroimmune Pharmacol       Date:  2015-11-04       Impact factor: 4.147

10.  Metabolic changes over the course of aging in a mouse model of tau deposition.

Authors:  Aurélie Joly-Amado; Karisa S Serraneau; Milene Brownlow; Caralina Marín de Evsikova; John R Speakman; Marcia N Gordon; Dave Morgan
Journal:  Neurobiol Aging       Date:  2016-04-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.